• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢素在儿童炎症性肠病中的应用:意大利的经验。

The use of ciclosporin in paediatric inflammatory bowel disease: an Italian experience.

作者信息

Barabino A, Torrente F, Castellano E, Gandullia P, Calvi A, Cucchiara S, De G L, Fontana M, Lionetti P, De Giacomo C, Gissi A

机构信息

Pediatric Gastroenterology, G Gaslini Institute, Genoa, Italy.

出版信息

Aliment Pharmacol Ther. 2002 Aug;16(8):1503-7. doi: 10.1046/j.1365-2036.2002.01308.x.

DOI:10.1046/j.1365-2036.2002.01308.x
PMID:12182750
Abstract

AIM

To asses the efficacy and safety of ciclosporin in a paediatric population with inflammatory bowel disease.

PATIENTS AND METHODS

Twenty-three Italian children treated with ciclosporin were studied retrospectively. The indications for treatment were severe unresponsive colitis, chronic active colitis or severe fistulizing Crohn's disease. The treatment duration, follow-up and causes of drug discontinuation were assessed.

RESULTS

Sixteen patients were treated intravenously for a mean time of 10 +/- 7 days (1-24 days) and 19 orally for a mean time of 133 days (17-660 days). The mean follow-up of all patients was 13.2 months. Ciclosporin was totally ineffective, being discontinued for surgery, in nine of 23 patients (39%); it was discontinued for partial response in three patients (13%). During treatment, clinical remission was achieved in eight children (35%) and maintained after drug withdrawal in four (17%). In severe unresponsive colitis, urgent colectomy was avoided in 12 (85%) of 14 patients who tolerated the drug. Side-effects appeared in six of 23 patients (26%), and three (13%) required ciclosporin to be discontinued due to neurotoxicity.

CONCLUSIONS

Ciclosporin shows disappointing long-term results in the treatment of refractory inflammatory bowel disease, but can play an important role in preventing urgent surgery in unresponsive severe colitis. Severe side-effects can occur.

摘要

目的

评估环孢素在儿童炎症性肠病患者中的疗效和安全性。

患者与方法

对23例接受环孢素治疗的意大利儿童进行回顾性研究。治疗指征为严重难治性结肠炎、慢性活动性结肠炎或严重瘘管性克罗恩病。评估治疗持续时间、随访情况及停药原因。

结果

16例患者接受静脉治疗,平均治疗时间为10±7天(1 - 24天);19例接受口服治疗,平均治疗时间为133天(17 - 660天)。所有患者的平均随访时间为13.2个月。23例患者中有9例(39%)环孢素完全无效,因手术停药;3例(13%)因部分缓解停药。治疗期间,8例儿童(35%)实现临床缓解,停药后4例(17%)仍维持缓解。在严重难治性结肠炎中,14例耐受该药物的患者中有12例(85%)避免了紧急结肠切除术。23例患者中有6例(26%)出现副作用,3例(13%)因神经毒性需要停用环孢素。

结论

环孢素在治疗难治性炎症性肠病方面显示出令人失望的长期效果,但在预防难治性严重结肠炎的紧急手术中可发挥重要作用。可能会出现严重副作用。

相似文献

1
The use of ciclosporin in paediatric inflammatory bowel disease: an Italian experience.环孢素在儿童炎症性肠病中的应用:意大利的经验。
Aliment Pharmacol Ther. 2002 Aug;16(8):1503-7. doi: 10.1046/j.1365-2036.2002.01308.x.
2
[Efficacy and safety of cyclosporine in the treatment of inflammatory bowel disease in children - a retrospective study].
Med Wieku Rozwoj. 2006 Apr-Jun;10(2):429-35.
3
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.通过RAND方法评估炎症性肠病中免疫抑制药物的适用性:意大利炎症性肠病研究小组(IG-IBD)立场声明
Dig Liver Dis. 2005 Jun;37(6):407-17. doi: 10.1016/j.dld.2004.12.013.
4
Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis.在严重的、激素难治性溃疡性结肠炎中,硫唑嘌呤联合静脉环孢素诱导缓解后的长期维持治疗中不使用口服环孢素。
Aliment Pharmacol Ther. 2002 Dec;16(12):2061-5. doi: 10.1046/j.1365-2036.2002.01385.x.
5
The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.108例激素难治性溃疡性结肠炎患者序贯挽救治疗中挽救治疗的有效性和安全性。
J Crohns Colitis. 2014 Nov;8(11):1427-37. doi: 10.1016/j.crohns.2014.05.004. Epub 2014 Jun 5.
6
Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review.英夫利昔单抗或环孢素治疗后溃疡性结肠炎患者的结肠切除术发生率:一项系统文献综述
Eur J Gastroenterol Hepatol. 2016 Apr;28(4):369-82. doi: 10.1097/MEG.0000000000000568.
7
Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.英夫利昔单抗挽救治疗环孢素治疗失败的皮质激素难治性溃疡性结肠炎:一项多中心研究。
Aliment Pharmacol Ther. 2012 Jan;35(2):275-83. doi: 10.1111/j.1365-2036.2011.04934.x. Epub 2011 Dec 5.
8
Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.挽救治疗对类固醇难治性急性重度溃疡性结肠炎的疗效:环孢素与英夫利昔单抗。
Aliment Pharmacol Ther. 2013 Aug;38(3):294-302. doi: 10.1111/apt.12375. Epub 2013 Jun 20.
9
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.环孢素与英夫利昔单抗治疗对静脉用类固醇无效的重度溃疡性结肠炎患者的疗效比较:一项平行、开放标签、随机对照试验。
Lancet. 2012 Dec 1;380(9857):1909-15. doi: 10.1016/S0140-6736(12)61084-8. Epub 2012 Oct 10.
10
Ciclosporin for severe refractory colitis.
Tunis Med. 2010 Jun;88(6):390-3.

引用本文的文献

1
Current therapy of inflammatory bowel disease in children.儿童炎症性肠病的当前治疗方法。
Paediatr Drugs. 2006;8(5):279-302. doi: 10.2165/00148581-200608050-00002.
2
Role of cyclosporin in preventing or delaying colectomy in children with severe ulcerative colitis.环孢素在预防或延缓重症溃疡性结肠炎患儿结肠切除术方面的作用。
Langenbecks Arch Surg. 2007 Mar;392(2):161-4. doi: 10.1007/s00423-006-0068-y. Epub 2006 Aug 15.